Johnson & Johnson
Johnson & Johnson has installed Ralph S. Larsen as its new chairman and chief executive.
Larsen, 50, succeeds James E. Burke, 64, who held the top posts since 1976 and led the world’s largest health-care company through the 1982 Tylenol poisoning crisis. The transition at the New Brunswick, N.J., company was previously announced.
Burke is retiring but will become chairman of the board’s strategic planning committee for one year. Also retiring is David R. Clare, 63, the president and chairman of the executive committee. He will be chairman of the finance committee for one year.
The job of president is being phased out. Instead, there will be a three-person office of the chairman that will include Larsen and two newly appointed vice chairmen, Robert E. Campbell and Robert N. Wilson.
Start your day right
Sign up for Essential California for news, features and recommendations from the L.A. Times and beyond in your inbox six days a week.
You may occasionally receive promotional content from the Los Angeles Times.
